Prognosis of VEGF inhibitors combined with laser therapy in patients with diabetic retinopathy

Prognosis of VEGF inhibitors combined with laser therapy in patients with diabetic retinopathy

AIM: To discuss the prognosis effects of vascular endothelial growth factor(VEGF)inhibitors combined with laser therapy in patients with diabetic retinopathy. <p>METHODS: Totally 120 patients(129 eyes)with diabetic retinopathy were selected from September 2014 to December 2015 in our Hospital....

Full description

Bibliographic Details
Main Authors:	Wei-Xiong Zhou, Zhao-Yao Liu
Format:	Article
Language:	English
Published:	Press of International Journal of Ophthalmology (IJO PRESS) 2017-02-01
Series:	Guoji Yanke Zazhi
Subjects:	vascular endothelial growth factor inhibitors laser therapy diabetic retinopathy visual acuity safety
Online Access:	http://ies.ijo.cn/cn_publish/2017/2/201702010.pdf

Similar Items

Effects and mechanism of anti-VEGF assisted PPV in the treatment of proliferative retinopathy
by: Si-Jun Fan, et al.
Published: (2017-10-01)

Effects of laser photocoagulation combined with anti-VEGF drugs at different time in the treatment of diabetic retinopathy
by: Shuang-Shuang Bi, et al.
Published: (2020-04-01)

Effect of Mingjing decoction with argon laser on plasma VEGF in patients with diabetic retinopathy
by: Ming Lu, et al.
Published: (2016-07-01)

Effects of laser combined with Ranibizumab on levels of PAI, t-PA and VEGF in aqueous humor in patients with proliferative diabetic retinopathy
by: Yan Lu, et al.
Published: (2020-01-01)

A study on visual outcome after laser photocoagulation in diabetic retinopathy cases
by: Hetaj K Sheth, et al.
Published: (2016-03-01)

Effect of fundus retinal argon laser photocoagulation combined with calcium dobesilate in the treatment of diabetic retinopathy
by: Jing Liu, et al.
Published: (2021-01-01)

Anti-VEGF treatment of diabetic macular edema in clinical practice: effectiveness and patterns of use (ECHO Study Report 1)
by: Blinder KJ, et al.
Published: (2017-02-01)

Clinical Course and Results of Anti-VEGF Therapy of Retinopathy of Prematurity
by: L. A. Katargina, et al.
Published: (2021-04-01)

Curative effect of 23G micro-invasive vitrectomy combined with intravitreal injection of Ranibizumab in the treatment of proliferative diabetic retinopathy
by: Wei Han, et al.
Published: (2021-03-01)

Anti-VEGF therapy in retinopathy of prematurity
by: Qin Peng, et al.
Published: (2020-11-01)

Aqueous concentrations of VEGF and soluble VEGF receptor-1 in diabetic retinopathy patients
by: Shaghayegh Haghjooy Javanmard, et al.
Published: (2012-01-01)

Analysis of visual acuity and macular edema in patients with diabetic retinopathy after laser treatment
by: Xiao-Qin Luo, et al.
Published: (2017-09-01)

Effects of intravitreous injection on the expression of vascular endothelial growth inhibitor in vitreous of proliferative diabetic retinopathy
by: Rui Shi, et al.
Published: (2015-06-01)

Researches advance on anti-VEGF medication for retinopathy of prematurity
by: Huan-Huan Zhao, et al.
Published: (2013-12-01)

Recent progress in the investigation of VEGF and PEDF of proliferative diabetic retinopathy
by: Xiao-Hong Chen, et al.
Published: (2015-01-01)

Clinical effect of laser photocoagulation combined with minimal doses of intravitreal Ranibizumab for aggressive posterior retinopathy of prematurity
by: He Cao, et al.
Published: (2019-11-01)

Sensibilidade ao contraste na retinopatia diabética tratada por panfotocoagulação com laser de argônio Contrast sensitivity in diabetic retinopathy treated with argon laser panphotocoagulation
by: Otacílio de Oliveira Maia Júnior, et al.
Published: (2007-10-01)

Roles of tissue plasminogen activator and its inhibitor in proliferative diabetic retinopathy
by: Shu-Ling Wu, et al.
Published: (2014-10-01)

Meta-analysis of long-term efficacy of vitrectomy combined with anti-VEGF in the treatment of proliferative diabetic retinopathy
by: Wen-Qiang Hu, et al.
Published: (2021-06-01)

Current Concepts in Diabetic Retinopathy
by: Su Jeong Song, et al.
Published: (2014-12-01)

Intravitreal Bevacizumab Alone Versus Combined Bevacizumab and Macular Grid Laser Photocoagulation in Diffuse Diabetic Macular Oedema
by: Fawaz Al Sarireh, et al.
Published: (2020-11-01)

Disease risk factor control and drug intervention in diabetic retinopathy
by: Xin Gong, et al.
Published: (2014-12-01)

Clinical study of laser photocoagulation combined with VEGF antagonists for DME
by: Da-Yong Yang, et al.
Published: (2018-06-01)

Anti-VEGF therapy in the management of retinopathy of prematurity: what we learn from representative animal models of oxygen-induced retinopathy
by: Wang H
Published: (2016-05-01)

The expression of HIT-1α and VEGF in proliferative diabetic retinopathy epiretinal membranes
by: Jian-Feng Cao, et al.
Published: (2013-05-01)

The Role of Frequency Doubling Technology Perimetry in Early Detection of Diabetic Retinopathy
by: Mario Bradvica, et al.
Published: (2020-01-01)

Research on AT-Ⅲ, PAI and t-PA in patients with different stages of diabetic retinopathy
by: Lu-Lu Jiang, et al.
Published: (2018-01-01)

Retinal vascular caliber changes after laser photocoagulation in diabetic retinopathy
by: Habibah Setyawati Muhiddin, et al.
Published: (2020-12-01)

The role of anti-vascular endothelial growth factor (anti-VEGF) in the management of proliferative diabetic retinopathy
by: Yue Zhao, et al.
Published: (2018-08-01)

Efficacy of fundus photocoagulation combined with triamcinolone acetonide on diabetic retinopathy
by: En-Xian Zhao, et al.
Published: (2018-11-01)

Treatment of retinopathy of prematurity:a review of conventional and promising new therapeutic options
by: Fatih Mehmet Mutlu, et al.
Published: (2013-04-01)

Comparison of the effectiveness of Conbercept versus Ranibizumab in the treatment of type 1 retinopathy of prematurity
by: Man-Hong Li*, et al.
Published: (2021-05-01)

Streptozotocin induced diabetic retinopathy in rat and the expression of vascular endothelial growth factor and its receptor
by: Chen-Yuan Gong, et al.
Published: (2013-10-01)

New opportunities in management of patients with retinopathy prematurity (literature review and analysis of own data)
by: L. A. Katargina, et al.
Published: (2020-12-01)

Effect of ranibizumab combined with vitrectomy on the serum VEGF-A and SDF-1 expression in patients with proliferative diabetic retinopathy
by: Wen Luo, et al.
Published: (2019-03-01)

Curative effect of Ranibizumab combined with laser photocoagulation for proliferative diabetic retinopathy
by: Fan-Yi Meng, et al.
Published: (2018-04-01)

Correlation of serum ICAM-1 and VEGF levels with microvascular injury in patients with senile diabetic retinopathy
by: Xing-Guang He, et al.
Published: (2018-02-01)

Changes in vitreous VEGF, bFGF and fibrosis in proliferative diabetic retinopathy after intravitreal bevacizumab
by: Jiu-Ke Li, et al.
Published: (2015-12-01)

Mechanism of worsening diabetic retinopathy with rapid lowering of blood glucose: the synergistic hypothesis
by: Ahmadou M. Jingi, et al.
Published: (2017-10-01)

Vitreomacular interface after anti-VEGF injections in diabetic macular edema
by: Carlos E. Veloso, et al.
Published: (2021-03-01)